宫颈上皮内瘤变锥切术后HPV持续感染情况及关联因素分析

Factors related to HPV infection after cervical conization for cervical intraepithelial neoplasia

  • 摘要:
    背景 宫颈上皮内瘤变(CIN)行宫颈锥切术后仍有人乳头瘤病毒(HPV)持续感染的问题,对于这部分患者的感染情况及关联因素仍未达成共识。
    目的 比较宫颈锥切术治疗宫颈上皮内瘤变(CIN)术后人乳头瘤病毒(HPV)持续感染资料,并进行关联因素分析。
    方法 回顾性分析 2017年9月— 2021年12月在解放军总医院第一医学中心妇产科行宫颈锥切术并参与术后随访至少一次的CIN患者临床资料,总样本1 895例,汇总其基本信息、术前HPV感染分型、手术及病理信息、术后HPV持续感染分型、术后疫苗接种信息,分析术后HPV持续阳性的相关因素。
    结果  所纳入患者样本,术前HPV阳性率79.37%;29.45%为HPV多重感染。锥切术后复查HPV持续阳性率达18.89%。后续部分样本的结局生存分析结果与其相似。术后HPV阳性组中,31 ~ 40岁占比较低,HPV16/18高危类型占比较高(P<0.05)。锥切术后病理结果:术后HPV持续阳性组和HPV阴性组比较:术前病理类型、手术前后病理级别差异、锥切直径等三指标差异显著(P<0.05)。术后3 ~ 6个月首次随访:HPV阳性组251例,与术前HPV分型不相同的有110例。HPV阴性组107例,与术前HPV分型不相同的有66例。追踪部分被随访者HPV疫苗接种情况:相对于未注射疫苗的被随访者,锥切术后接种疫苗者HPV感染率明显偏低(P<0.05)。多因素回归结果:对术后HPV感染而言,术前病理级别(加重)是危险关联因素(OR>1),接种疫苗是保护影响因素(OR<1)。均有P<0.05。
    结论  锥切术后接种HPV疫苗对预防HPV持续感染具有显著效果。

     

    Abstract:
    Background Human papillomavirus (HPV) infection may exist after cervical conectomy for cervical intraepithelial neoplasia (CIN). There is still no consensus on the infection status and associated factors in these patients.
    Objective To compare the data of persistent human papillomavirus (HPV) infection after cervical conectomy for cervical intraepithelial neoplasia (CIN) and analyze the associated factors.
    Methods Clinical data about 1 895 CIN patients who underwent cervical conectomy in the Department of Obstetrics and Gynecology of the First Medical Center of Chinese PLA General Hospital from September 2017 to December 2021 and participated in postoperative follow-up at least once were retrospectively analyzed. The basic information, preoperative HPV infection type, surgical and pathological information, postoperative HPV persistent infection type, postoperative vaccination information were summarized, and the related factors of postoperative HPV persistent positive were analyzed.
    Results The preoperative HPV positive rate was 79.37%, and 29.45% of them were HPV multiple infections. The continuous positive rate of HPV after coning was 18.89%. The outcome survival analysis results of the subsequent samples were similar. In the postoperative HPV-positive group, the proportion of 31-40 years old was relatively low, and the proportion of HPV16/18 high-risk types was relatively high (P < 0.05). There were significant differences in preoperative pathological type, pathological grade and conectomy diameter before and after surgery between the HPV-positive group and the HPV-negative group (P < 0.05). The first follow-up was 3 to 6 months after surgery. There were 251 cases in the HPV-positive group, of which 110 cases were different from the preoperative HPV typing. There were 107 cases in HPV-negative group, and 66 cases were different from preoperative HPV typing. Compared with the interviewees who did not receive the vaccine, the HPV infection rate of those who received the vaccine after coning was significantly lower (P < 0.05). Multivariate regression results showed that for postoperative HPV infection, preoperative pathologic grade (aggravation) was the risk associated factor (OR > 1), and vaccination was the protective factor (OR < 1).
    Conclusion HPV vaccination after coning has a significant effect on the prevention of persistent HPV infection.

     

/

返回文章
返回